Latest filing published 07 Oct 2026 for Ginkgo Bioworks Holdings, Inc., €32k. Read the official filing
Steven P. Coen discloses dealings in Ginkgo Bioworks Holdings, Inc. to SEC (Form 4). Over a trading history stretching from 1 May 2024 to 5 October 2026, the count stands at 39 filings.
Sales make up the whole of the open-market record (8 sales, €311k). Other entries cover 31 option exercises. 2026 to date brings no purchases and 6 sales.
The record was last updated on 7 October 2026 with an open-market sale (€32k) in Ginkgo Bioworks Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations